Focal Segmental Glomerulosclerosis clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 18 years and up
The purpose of this Phase 2 adaptive study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of PF-06730512 following multiple intravenous infusion in adult subjects with FSGS.
San Francisco, California and other locations